CAP4 GAG (UNA) and CAP5 GAG (ENE)

CAP4 GAG (UNA) and CAP5 GAG (ENE) Cap Analogs

CAP4 and CAP5 are variations of m7GpppAmG trinucleotide, the first generation of the cap analog. The innovation of CAP 4 and CAP 5 is on the m7G cap, with CAP4 having a UNA with a unlocked nucleic acid structure and CAP5 having a double bond between the ribose ring and the first phosphate group.

Technical Data

IVT Performance Comparison of Novel Cap Analogs

IVT Reaction System

The table shows the manufacturing efficiency of CAP GAG, a type of mRNA cap analog, by two different manufacturers: Company A and Areterna LLC. The table includes data on mRNA yield, mRNA integrity, capping efficiency, and dsRNA ratio.

Cap Analog Vendor mRNA Yield (ug) mRNA Integrity Capping Efficiency dsRNA Ratio
CAP GAG Company A 183 90.2% 98.5% 0.04%
CAP GAG (UNA) Areterna 187 91.3% 99.1% 0.03%
CAP GAG (ENE) 184 89.5% 98.9% 0.04%

 

Decapping Enzyme Performance Comparison

Decapping Reaction System

This table shows the results of a decapping reaction system on RNA with a 5′ cap, using a decapping enzyme with different cap analogs.

Cap Analog
Vendor Remaining Cap% (Replicate 1) Remaining Cap% (Replicate 2) Remaining Cap% (Replicate 3)
CAP GAG Company A 22.5% 19.3% 28.4%
CAP GAG (UNA) Areterna 77.3% 82.5% 84.0%
CAP GAG (ENE) 35.9% 35.2% 34.4%

 

In-Vivo Performance of mRNA’s Capped with Novel Cap Analogs

The image shows the expression of GFP from mRNA constructs with different CAP’s. The images were taken at 6, 24, 48, 72, and 96 hours after transfection.

This image shows luciferase protein expression from mRNA constructs with different CAP’s. The mice were monitored for 6, 24, 48, and 72 hours.

Product Details

CAP 4 m7G(UNA)(5')ppp(5')(2'OMeA)pG 100mM Ammonium Solution

 

SKU Size Purity: >98%
CAP4011-0.1 100μL
CAP4011-1 1mL
CAP4011-10 10mL
CAP4011-100 100mL
CAP4011-500 500mL

 

CAP 5 m7G(5')vppp(5')(2'OMeA)pG 100mM Ammonium Solution
SKU Size Purity: >98%
CAP5011-0.1 100μL
CAP5011-1 1mL
CAP5011-10 10mL
CAP5011-100 100mL
CAP5011-500 500mL